Healthcare REIT (AHR) Q3 2026 Earnings Call Transcript

American Healthcare REIT (AHR) reported Q3 2026 earnings with same-store NOI growth of 13.8%, raising full-year NFFO per diluted share growth guidance to over 30%. The company completed $2.1B in investments and has a $1B pipeline, while maintaining a net debt to EBITDA ratio of 1.9x. AHR emphasized its strategy of organic growth, accretive investments, and balance sheet management.

Original reporting

finance.yahoo.com

Published Nov 7, 2026, 6:17 PM UTC

Analysis

AlphAI AI DeskAI-generated

Added to AlphAI Nov 7, 2026, 6:24 PM UTC. Informational, not investment advice.

How this was made

AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About AlphAI AI Desk Scoring methodology Report an issue

Healthcare REIT (AHR) Q3 2026 Earnings Call Transcript — source image — Source · finance.yahoo.com

Decision brief

The 30-second read

$AHRBullishHigh

Why it matters

The strong NOI growth and upgraded guidance are likely to drive short‑term buying interest.

Market read

New earnings data and guidance for AHR represent fresh material that can move the stock.

What to watch

Potential headwinds from rising interest rates could offset growth.

Relevance 8/10Novelty 8/10Timing: post‑market today

Background

Healthcare REIT (AHR) provided its Q3 2026 earnings call transcript with operational and financial highlights.

Company-level read

Ticker impact

AI estimates · verify against primary disclosures

$AHRBullishHigh confidence

Context

Q3 2026 earnings call disclosed 13.8% same-store NOI growth and raised full-year NFFO guidance to >30% YoY.

Expected impact

likely upward pressure as investors price in stronger growth and higher guidance

Evidence & confidence

The disclosed NOI growth and raised guidance are new, material data for a mid‑cap REIT.

Market effects

Sector

Positive signal for the healthcare REIT sector may lift peers.

Regional

U.S. REIT market could see modest gains.

Global

Limited to U.S. real‑estate investors.

Counterpoint

What could challenge this read

If guidance already priced in, the stock may face profit‑taking.

Key entities

Executive
Jeffrey Hanson
Chairman and CEO of AHR delivering the earnings commentary.

Read at source ← All news

$AHRMed

American Healthcare REIT forecasts $2.23-$2.26 2026 NFFO per share as same-store NOI growth target rises to 12%-14% (NYSE:AHR)

American Healthcare REIT (AHR) raised its 2026 normalized FFO guidance to $2.23-$2.26 per share and increased its same-store NOI growth target to 12%-14%. CEO Jeffrey Hanson reported 13.8% same-store NOI growth, marking 11 consecutive quarters of double-digit growth.

seekingalpha.comNov 6

$AHRMedAI 8/10

American Healthcare REIT Q3 Earnings Call Highlights

American Healthcare REIT (AHR) reported Q3 gains in senior housing occupancy and margins. SHOP same-store NOI rose 28.2% YoY, with occupancy at 90%. Trilogy's NOI grew 15.7% YoY, occupancy at 91.2%. The company invested $2.1B YTD, including six Kensington communities for $572M. AHR's net debt to EBITDA is 1.9x, with $1.3B in funding available. The company plans to focus on SHOP and Trilogy for future growth, selling non-core assets.

finance.yahoo.comNov 6

$AHRHigh

American Healthcare REIT Sets Bar Higher for SHOP to Fuel Next Growth Stage

American Healthcare REIT (AHR) reported 28.2% Q3 same-store NOI growth, up from 20.5% in Q2. The company expanded its SHOP segment and raised full-year NOI growth outlook to 23-26%. AHR stock rose 3.23% to $57.91. Management emphasized selective acquisitions and long-term operator partnerships.

seniorhousingnews.comNov 6

$AHRHigh

American Healthcare REIT Launches $1.75 Billion At-the-Market Equity Program

American Healthcare REIT (AHR) launched a $1.75B at-the-market equity program, terminating a prior $170.1M unsold offering. Proceeds may support general corporate purposes and future investments. The new agreement includes forward sale provisions and is effective immediately. AHR's 8-K filing on Nov 06, 2026, details the changes.

tradingview.comNov 6

$AHRHighAI 8/10

Truist reiterates Buy on American Healthcare REIT stock after earnings

Truist reiterated a Buy rating and $61 price target on American Healthcare REIT (AHR) after its earnings beat estimates, driven by senior housing revenue growth and lower expenses. The stock is up 20.88% YTD, but some analysts consider it overvalued. KeyBanc raised its target to $68, while Citizens maintained a Market Outperform rating with a $65 target. Raymond James initiated coverage with a Strong Buy, citing strong acquisition activity and partnerships.

investing.comNov 6